anidulafungin | CMAC

anidulafungin

Pharmacoeconomic Analysis of Anidulafungin (Eraxis®) Use in the Treatment of Invasive Candidiasis

Invasive candidiasis is a common infectious complication in intensive care units and hematological malignancies chemotherapy units. This study presents data from the first-in-Russia health economics review of the anidulafungin use in the treatment of …

Anidulafungin: Brief Clinical Pharmacology Review

Invasive fungal infections are an actual problem of the modern medicine. This is due to the widening population of the affected patients and the increasing number of fungal strains that are resistant to the previously extensively used antifungal …